SC
AGIO icon

Steven Cohen’s Agios Pharmaceuticals AGIO Stock Holding History

Steven Cohen’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,700
Closed -$497K – 3946
2026
Q1 		$497K Buy
+14,700
New +$417K ﹤0.01% 3116

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Steven Cohen's AGIO Position: Q2 2026 in Review

Steven Cohen opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 506,344 shares worth $18.8M. The stake represents 0.02% of the portfolio and ranks #926 among its holdings. This is a return to the name: Steven Cohen previously reported a position in AGIO as recently as Q4 2025.

Steven Cohen first reported a position in AGIO in Q2 2014 and has held it in 20 quarters since. The position peaked at $33.2M in Q1 2018. 236 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Steven Cohen held 506,344 shares of Agios Pharmaceuticals worth $18.8M as of Q2 2026.
  • Agios Pharmaceuticals was a new Steven Cohen position in Q2 2026.
  • Agios Pharmaceuticals made up 0.02% of Steven Cohen's portfolio in Q2 2026, its #926 holding.
  • Steven Cohen first reported a position in Agios Pharmaceuticals in Q2 2014 and has held it in 20 quarters since.
  • Steven Cohen's Agios Pharmaceuticals position peaked at $33.2M in Q1 2018.
  • 236 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.